Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by kevinNashon Nov 09, 2018 12:48pm
152 Views
Post# 28951265

RE:Nearly down to the wire.

RE:Nearly down to the wire.
Jazzinsky wrote: Will something happen in the next two months?  If I go by what has been posted here PLI needs cash.   Will it be from a deal or from a new issue.  Uncertainty breeds distrust.  Uncertainly from managment breeds disgust.  Why wouldn't PLI correct this situation and fast?  Answers or  greater insight from other posters would be appreciated.


Nobody knows these answers.  Pierre should sign a partnership if he had any respect for the shareholders, but so far he's completely failed to support shareholder value.  What about the fast track?  Anybody?  Have they arrnaged a new approval date?   

Pierre just needs to resign.  

Bullboard Posts